{"title":"Outcomes of transsphenoidal surgery in 34 small dogs with pituitary-dependent hypercortisolism.","authors":"Sachiyo Tanaka, Shuji Suzuki, Takahiro Teshima, Hirokazu Ishino, Asaka Kawana, Takahiro Taoda, Yasushi Hara","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to evaluate the clinical outcomes of transsphenoidal surgery (TSS) in dogs weighing < 15 kg with pituitary-dependent hypercortisolism (PDH).</p><p><strong>Animals: </strong>The study included 34 dogs, each weighing < 15 kg, diagnosed with PDH, and undergoing TSS at our facility between 1999 and 2021.</p><p><strong>Procedure: </strong>Postoperative assessments included fatal complications within 4 wk, the extent of mass resection, the duration of central diabetes insipidus, long-term survival, and duration of remission.</p><p><strong>Results: </strong>Five dogs died within 4 wk after TSS. Complete resections were completed in 28 dogs, whereas 6 dogs underwent partial resection. Factors associated with partial resection included a higher pituitary-to-brain ratio (odds ratio: 112 705.8; <i>P</i> = 0.014). The median duration of central diabetes insipidus after TSS was 9.5 d. The median long-term postoperative survival was 1228 d. The estimated censored survival rates were 83 and 69% at 1 and 2 y postoperatively, respectively. Recurrence of PDH was observed in 2 dogs, with a median postoperative remission duration of 1188 d. Estimated recurrence-free rates were 90 and 90% at 1 and 2 y postoperatively, respectively.</p><p><strong>Conclusion and clinical relevance: </strong>Transsphenoidal surgery is an effective treatment for PDH in dogs weighing < 15 kg, particularly when the pituitary gland is small.</p>","PeriodicalId":9429,"journal":{"name":"Canadian Veterinary Journal-revue Veterinaire Canadienne","volume":"66 10","pages":"1094-1103"},"PeriodicalIF":1.0000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12477731/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian Veterinary Journal-revue Veterinaire Canadienne","FirstCategoryId":"97","ListUrlMain":"","RegionNum":4,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"VETERINARY SCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: This study aimed to evaluate the clinical outcomes of transsphenoidal surgery (TSS) in dogs weighing < 15 kg with pituitary-dependent hypercortisolism (PDH).
Animals: The study included 34 dogs, each weighing < 15 kg, diagnosed with PDH, and undergoing TSS at our facility between 1999 and 2021.
Procedure: Postoperative assessments included fatal complications within 4 wk, the extent of mass resection, the duration of central diabetes insipidus, long-term survival, and duration of remission.
Results: Five dogs died within 4 wk after TSS. Complete resections were completed in 28 dogs, whereas 6 dogs underwent partial resection. Factors associated with partial resection included a higher pituitary-to-brain ratio (odds ratio: 112 705.8; P = 0.014). The median duration of central diabetes insipidus after TSS was 9.5 d. The median long-term postoperative survival was 1228 d. The estimated censored survival rates were 83 and 69% at 1 and 2 y postoperatively, respectively. Recurrence of PDH was observed in 2 dogs, with a median postoperative remission duration of 1188 d. Estimated recurrence-free rates were 90 and 90% at 1 and 2 y postoperatively, respectively.
Conclusion and clinical relevance: Transsphenoidal surgery is an effective treatment for PDH in dogs weighing < 15 kg, particularly when the pituitary gland is small.
期刊介绍:
The Canadian Veterinary Journal (CVJ) provides a forum for the discussion of all matters relevant to the veterinary profession. The mission of the Journal is to educate by informing readers of progress in clinical veterinary medicine, clinical veterinary research, and related fields of endeavor. The key objective of The CVJ is to promote the art and science of veterinary medicine and the betterment of animal health.
A report suggesting that animals have been unnecessarily subjected to adverse, stressful, or harsh conditions or treatments will not be processed for publication. Experimental studies using animals will only be considered for publication if the studies have been approved by an institutional animal care committee, or equivalent, and the guidelines of the Canadian Council on Animal Care, or equivalent, have been followed by the author(s).